Description

Zepbound® (Tirzepatide) Injection 10 mg / 0.5 mL. Each box includes four single-dose, pen-style prefilled syringes, each delivering 10 mg of tirzepatide in 0.5 mL, designed for once-weekly subcutaneous injection.

Why Buy Zepbound from Weight Loss RX?

• FDA-Approved Weight Loss Injection
• Advanced Dual GIP + GLP-1 Therapy
• Once-Weekly Dosing Convenience
• Clinically Proven Weight Reduction
• Pre-Filled, Easy-to-Use Pens
• Refrigerated, Temperature-Controlled Shipping
• Secure RX Fulfillment in the USA

Product Overview

Brand Name: Zepbound®
Generic Name: Tirzepatide
Manufacturer: Eli Lilly and Company
Drug Class: Dual GIP & GLP-1 Receptor Agonist
Prescription Required: Yes

Strength & Packaging

• 10 mg / 0.5 mL per pen
• 4 single-dose pens per box
• Weekly dosing (28-day supply)

Route of Administration

• Subcutaneous injection (abdomen, thigh, or upper arm)

FDA-Approved Indication

Zepbound® is approved for chronic weight management in adults:

• With BMI ≥30 (obesity), or
• With BMI ≥27 (overweight) plus at least one weight-related condition, such as:
  • High blood pressure
  • Type 2 diabetes
  • High cholesterol

Zepbound is intended to be used alongside a reduced-calorie diet and increased physical activity.

How Zepbound (Tirzepatide) Works

Zepbound activates two key metabolic hormone receptors:

GLP-1 Receptor Effects

• Reduces appetite
• Slows gastric emptying
• Enhances insulin response

GIP Receptor Effects

• Improves metabolic efficiency
• Enhances fat utilization
• Supports long-term weight reduction

This dual-action mechanism leads to greater appetite control, sustained satiety, and significant weight loss compared to single-pathway therapies.

Clinical Results

In FDA-reviewed clinical trials:

• Participants lost up to 20% or more of body weight
• Significant improvements in metabolic health markers
• Results sustained with continued weekly use

Dosage & Administration

• Inject once weekly
• Same day each week, with or without food
• Rotate injection sites to prevent irritation

Injection Sites

• Abdomen
• Thigh
• Upper arm

Always follow your healthcare provider’s titration schedule.

Storage & Shipping Information

Storage Requirements

• Refrigerate at 36°F–46°F (2°C–8°C)
• Do not freeze
• Store in original packaging
• Protect from light

Shipping Details

• Refrigerated item
• Next Day Air
• Signature required upon delivery

Prescription medications are not returnable

Possible Side Effects

Common Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Decreased appetite
• Fatigue

Serious Side Effects (Seek Medical Attention)

• Pancreatitis
• Gallbladder disease
• Kidney problems
• Severe allergic reactions

Important Safety Information

• Thyroid C-Cell Tumors: Contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
• Pancreatitis: Discontinue if suspected
• Hypoglycemia Risk: Increased when combined with insulin or sulfonylureas
• Pregnancy & Breastfeeding: Not recommended

Use only as prescribed by a licensed healthcare provider.